Artiva Biotherapeutics, Inc. (ARTV) Return on equity 2024–2025
Artiva Biotherapeutics, Inc. (ARTV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-76.3%FY2025 · since FY2024: -35.0% → -76.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -76.3% | -41.2 pp |
| FY2024 | -35.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating marginARTV Operating cash flowARTV Free cash flowARTV Capital expendituresARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →